MalcolmASmithMD
Pulmonology • Texarkana, TXCritical Care Medicine, Interventional Pulmonology, Sleep Medicine
Physician
Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5002 Cowhorn Creek Rd
Texarkana, TX 75503Phone+1 903-614-3000Fax+1 903-614-3525
Summary
- Dr. Malcolm Smith is a pulmonologist in Texarkana, TX and is affiliated with multiple hospitals in the area, including Wadley Regional Medical Center and CHRISTUS St. Michael Health System. He received his medical degree from University of Arkansas for Medical Sciences (UAMS) College of Medicine and has been in practice 27 years. He specializes in critical care medicine, interventional pulmonology, and sleep medicine and is experienced in critical care medicine.
Education & Training
Emory University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996- Emory University School of MedicineResidency, Internal Medicine, 1990 - 1993
University of Arkansas For Medical Sciences College of MedicineClass of 1990
Certifications & Licensure
TX State Medical License 1996 - 2024
OK State Medical License 2020 - 2020
GA State Medical License 1993 - 1997
AR State Medical License 1990 - 1991- National Board of Physicians and Surgeons Critical Care Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Pulmonary Disease
- National Board of Physicians and Surgeons Sleep Medicine
Publications & Presentations
PubMed
- 18 citationsEvaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models.Raushan T. Kurmasheva, Abhik M Bandyopadhyay, Edward Favours, Vanessa Del Pozo, Samson Ghilu
Pediatric Blood & Cancer. 2019-08-01 - 16 citationsPreclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts.Luke Jones, Hannah McCalmont, Kathryn Evans, Chelsea Mayoh, Raushan T. Kurmasheva
Pediatric Blood & Cancer. 2019-08-01 - 564 citationsPan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumoursXiaotu Ma, Yu Liu, Yanling Liu, Ludmil B. Alexandrov, Michael N. Edmonson
Nature. 2018-02-28
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
